Administration of Rho kinase inhibitor eye drops (10mM Y-27632) 4 times daily
Sponsors
Department of Ophthalmology, Kyoto Prefectural University of Medicine
Conditions
Corneal endothelial dysfunction
Unknown Phase
The effect of Rho kinase inhibitor for the treatment of corneal endothelial dysfunction: the 2nd step
Active, not recruitingJPRN-UMIN000003625
Start: 2010-05-01Target: 30Updated: 2026-06-29
The effect of Rho kinase inhibitor on corneal endothelial dysfunction: the 1st step
Active, not recruitingJPRN-UMIN000003624
Start: 2010-05-01Target: 10Updated: 2026-06-29